Showing results (91-100 of 144) with videos related to
Sort By:
Pageof 15
Clinical Therapeutics|November 7, 2024
Clinical Burden and Health Care Resource Utilization Associated With Managing Sickle Cell Disease With Recurrent Vaso-occlusive Crises in EnglandChuka Udeze, Nelly F Ly, Fiona C Ingleby, et al.The Patient|March 26, 2024
Health-Related Quality-of-Life Impacts Associated with Transfusion-Dependent β-Thalassemia in the USA and UK: A Qualitative AssessmentJennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, et al.Advances in Therapy|December 16, 2024
Qualitative Assessment of Health-Related Quality of Life Impacts Associated with Sickle Cell Disease in the United States and United KingdomJennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, et al.American Journal of Cancer Research|November 17, 2025
Hexokinase 2 promotes tumor development and progressionGuojuan Wang, Yujuan Lai, Xiudan Chen, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 29, 2021
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and RecommendationsLouis P Garrison, Ed Pezalla, Adrian Towse, et al.Journal of Medical Economics|December 15, 2015
Real-world dosing and drug costs with everolimus or axitinib as second targeted therapies for advanced renal cell carcinoma: a retrospective chart review in the USSumanta K Pal, Eric Jonasch, James E Signorovitch, et al.Advances in Therapy|November 21, 2025
Clinical Complications, Mortality, and Healthcare Resource Utilization of Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in Ontario, Canada: A Retrospective Cohort StudyLauren Lilly, Chuka Udeze, Natalie Nightingale, et al.Cancer Chemotherapy and Pharmacology|November 15, 2014
TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenograftsJamie L Croucher, Radhika Iyer, Nanxin Li, et al.Clinical Genitourinary Cancer|December 29, 2015
Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart ReviewsSumanta K Pal, James E Signorovitch, William M Reichmann, et al.Science (New York, N.Y.)|August 21, 2010
mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonistsNanxin Li, Boyoung Lee, Rong-Jian Liu, et al.Pageof 15